Kevin F. McLaughlin, SVP, CFO and Treasurer at ACCELERON PHARMA INC (XLRN), sold 23,706 shares at $50.28 ($1.2M) on 2019-12-13, disclosed to the SEC on 2019-12-17.
Open-market sale of $1.2M XLRN by SVP, CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.28 | 11,853 | $596K | 50.0% |
| 2 | $50.28 | 11,853 | $596K | 50.0% |
| Total | $50.28 avg | 23,706 | $1.2M | 100% |
| Filing → |
| VCEL | SELL | 2026-02-13 | $243K | — | Filing → |
| IVVD | BUY | 2025-11-20 | $125K | — | Filing → |
| VCEL | SELL | 2025-11-12 | $270K | — | Filing → |